BRIEF-Beigene presents preliminary phase 1 data for bgb-a317
September 28, 2017 at 10:07 AM EDT
* Beigene presents preliminary phase 1 data for bgb-a317 in chinese patients with advanced tumors at the 20th annual meeting of CSCO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.